Radiation-induced increase in invasive potential of human pancreatic cancer cells and its blockade by a matrix metalloproteinase inhibitor, CGS27023

Li Wu Qian, Kazuhiro Mizumoto, Taro Urashima, Eishi Nagai, Naoki Maehara, Norihiro Sato, Motowo Nakajima, Masao Tanaka

Research output: Contribution to journalArticle

134 Citations (Scopus)

Abstract

Purpose: Radiotherapy remains a major therapeutic option for patients with advanced pancreatic cancer. Nevertheless, the effects of irradiation on malignant biological behaviors (e.g., migration and invasion of cancer cells) have yet to be clarified. Thus, we conducted an in vitro study to investigate the radiation-induced alterations around cell migration and invasion capacity. Experiment design: Three cell lines from human pancreatic cancer were included in the study. γ-radiation was used for irradiation treatment. Cell migration and invasion ability were evaluated by Transwell migration assay and Matrigel invasion assay. The activity of MMP-2 and 9, and expression of urokinase-type plasminogen activator were investigated with gelatin zymography and immunoblot, respectively. Results: Irradiation enhances invasive potential in some pancreatic cancer cells, whereas it significantly inhibits cell proliferation and migration. This hitherto unknown biological effect of irradiation involves enhanced matrix metalloproteinase (MMP)-2 activity. Consequently, simultaneous administration of an MMP inhibitor, CGS27023A, suppresses the radiation-enhanced invasion through blockade of transition of MMP-2 from latent type to active type. Conclusion: Because radiation may increase invasion ability through activating MMP proteolytic system, simultaneous administration of the MMP inhibitor during radiotherapy could be a potent adjuvant therapeutic approach to improve the efficacy of radiotherapy for pancreatic cancer.

Original languageEnglish
Pages (from-to)1223-1227
Number of pages5
JournalClinical Cancer Research
Volume8
Issue number4
Publication statusPublished - Apr 1 2002

Fingerprint

Matrix Metalloproteinase Inhibitors
Pancreatic Neoplasms
Matrix Metalloproteinase 2
Radiation
Cell Movement
Aptitude
Radiotherapy
Matrix Metalloproteinase 9
Urokinase-Type Plasminogen Activator
Gelatin
Matrix Metalloproteinases
Therapeutics
Cell Proliferation
Cell Line
Neoplasms

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Radiation-induced increase in invasive potential of human pancreatic cancer cells and its blockade by a matrix metalloproteinase inhibitor, CGS27023. / Qian, Li Wu; Mizumoto, Kazuhiro; Urashima, Taro; Nagai, Eishi; Maehara, Naoki; Sato, Norihiro; Nakajima, Motowo; Tanaka, Masao.

In: Clinical Cancer Research, Vol. 8, No. 4, 01.04.2002, p. 1223-1227.

Research output: Contribution to journalArticle

Qian, Li Wu ; Mizumoto, Kazuhiro ; Urashima, Taro ; Nagai, Eishi ; Maehara, Naoki ; Sato, Norihiro ; Nakajima, Motowo ; Tanaka, Masao. / Radiation-induced increase in invasive potential of human pancreatic cancer cells and its blockade by a matrix metalloproteinase inhibitor, CGS27023. In: Clinical Cancer Research. 2002 ; Vol. 8, No. 4. pp. 1223-1227.
@article{08ec356e0416452187e005ba4cb36514,
title = "Radiation-induced increase in invasive potential of human pancreatic cancer cells and its blockade by a matrix metalloproteinase inhibitor, CGS27023",
abstract = "Purpose: Radiotherapy remains a major therapeutic option for patients with advanced pancreatic cancer. Nevertheless, the effects of irradiation on malignant biological behaviors (e.g., migration and invasion of cancer cells) have yet to be clarified. Thus, we conducted an in vitro study to investigate the radiation-induced alterations around cell migration and invasion capacity. Experiment design: Three cell lines from human pancreatic cancer were included in the study. γ-radiation was used for irradiation treatment. Cell migration and invasion ability were evaluated by Transwell migration assay and Matrigel invasion assay. The activity of MMP-2 and 9, and expression of urokinase-type plasminogen activator were investigated with gelatin zymography and immunoblot, respectively. Results: Irradiation enhances invasive potential in some pancreatic cancer cells, whereas it significantly inhibits cell proliferation and migration. This hitherto unknown biological effect of irradiation involves enhanced matrix metalloproteinase (MMP)-2 activity. Consequently, simultaneous administration of an MMP inhibitor, CGS27023A, suppresses the radiation-enhanced invasion through blockade of transition of MMP-2 from latent type to active type. Conclusion: Because radiation may increase invasion ability through activating MMP proteolytic system, simultaneous administration of the MMP inhibitor during radiotherapy could be a potent adjuvant therapeutic approach to improve the efficacy of radiotherapy for pancreatic cancer.",
author = "Qian, {Li Wu} and Kazuhiro Mizumoto and Taro Urashima and Eishi Nagai and Naoki Maehara and Norihiro Sato and Motowo Nakajima and Masao Tanaka",
year = "2002",
month = "4",
day = "1",
language = "English",
volume = "8",
pages = "1223--1227",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "4",

}

TY - JOUR

T1 - Radiation-induced increase in invasive potential of human pancreatic cancer cells and its blockade by a matrix metalloproteinase inhibitor, CGS27023

AU - Qian, Li Wu

AU - Mizumoto, Kazuhiro

AU - Urashima, Taro

AU - Nagai, Eishi

AU - Maehara, Naoki

AU - Sato, Norihiro

AU - Nakajima, Motowo

AU - Tanaka, Masao

PY - 2002/4/1

Y1 - 2002/4/1

N2 - Purpose: Radiotherapy remains a major therapeutic option for patients with advanced pancreatic cancer. Nevertheless, the effects of irradiation on malignant biological behaviors (e.g., migration and invasion of cancer cells) have yet to be clarified. Thus, we conducted an in vitro study to investigate the radiation-induced alterations around cell migration and invasion capacity. Experiment design: Three cell lines from human pancreatic cancer were included in the study. γ-radiation was used for irradiation treatment. Cell migration and invasion ability were evaluated by Transwell migration assay and Matrigel invasion assay. The activity of MMP-2 and 9, and expression of urokinase-type plasminogen activator were investigated with gelatin zymography and immunoblot, respectively. Results: Irradiation enhances invasive potential in some pancreatic cancer cells, whereas it significantly inhibits cell proliferation and migration. This hitherto unknown biological effect of irradiation involves enhanced matrix metalloproteinase (MMP)-2 activity. Consequently, simultaneous administration of an MMP inhibitor, CGS27023A, suppresses the radiation-enhanced invasion through blockade of transition of MMP-2 from latent type to active type. Conclusion: Because radiation may increase invasion ability through activating MMP proteolytic system, simultaneous administration of the MMP inhibitor during radiotherapy could be a potent adjuvant therapeutic approach to improve the efficacy of radiotherapy for pancreatic cancer.

AB - Purpose: Radiotherapy remains a major therapeutic option for patients with advanced pancreatic cancer. Nevertheless, the effects of irradiation on malignant biological behaviors (e.g., migration and invasion of cancer cells) have yet to be clarified. Thus, we conducted an in vitro study to investigate the radiation-induced alterations around cell migration and invasion capacity. Experiment design: Three cell lines from human pancreatic cancer were included in the study. γ-radiation was used for irradiation treatment. Cell migration and invasion ability were evaluated by Transwell migration assay and Matrigel invasion assay. The activity of MMP-2 and 9, and expression of urokinase-type plasminogen activator were investigated with gelatin zymography and immunoblot, respectively. Results: Irradiation enhances invasive potential in some pancreatic cancer cells, whereas it significantly inhibits cell proliferation and migration. This hitherto unknown biological effect of irradiation involves enhanced matrix metalloproteinase (MMP)-2 activity. Consequently, simultaneous administration of an MMP inhibitor, CGS27023A, suppresses the radiation-enhanced invasion through blockade of transition of MMP-2 from latent type to active type. Conclusion: Because radiation may increase invasion ability through activating MMP proteolytic system, simultaneous administration of the MMP inhibitor during radiotherapy could be a potent adjuvant therapeutic approach to improve the efficacy of radiotherapy for pancreatic cancer.

UR - http://www.scopus.com/inward/record.url?scp=0036554937&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036554937&partnerID=8YFLogxK

M3 - Article

VL - 8

SP - 1223

EP - 1227

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 4

ER -